Connect with us

Marijuana Stocks

Syqe, Israeli Medical Cannabis Inhaler Maker, Looks to IPO on Toronto Stock Exchange

Jane Summers



Syqe, Israeli Medical Cannabis Inhaler Maker, Looks to IPO on Toronto Stock Exchange

Syqe Medical, an Israeli company, is aiming toward an IPO on the Toronto Stock Exchange, according to Israeli news source, Globes. Syqe has developed and is marking inhalers for medical cannabis that provide users with an exact dosage of CBD. The inhaler has precise control over, and the user can manage and change the dosage by an attendant monitor.

According to the company website, Syqe is a pharma-tech company developing technologies that enable the precise delivery of molecules directly from plants.

“We believe it is our responsibility to relieve the suffering of as many patients as possible in the fastest possible way, using our breakthrough technology. The Syqe platform is the first drug delivery platform in medical history to successfully administer whole plants at pharmaceutical standards.”

Perry Davidson founded and managed Syqe, and has successfully raised $50 million last year in a financing round led by Shavit Capital. The company’s products have been marketed by Israeli Pharmaceutical giant Teva since early this summer.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Follow Times of CBD News

popular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide is the most active daily cannabis news publication online inviting all readers to come for the headlines and stay for the insights. The primary focus is on curating latest CBD news updates, marijuana market movements and researched hemp-based product user guides. While everything is here for educational, informational purposes only, quality is always the priority and fact checking sources with industry-leading accuracy in reporting is at the top of the list of this emerging, innovative industry.

Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

Got news? Email us [email protected]

Trending Cannabis News